X-71529785-C-T

Variant summary

Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong

The ENST00000437147.8(TAF1):​n.*247C>T variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000276 in 326,523 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 1 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 22)
Exomes 𝑓: 0.000033 ( 0 hom. 1 hem. )

Consequence

TAF1
ENST00000437147.8 non_coding_transcript_exon

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity no assertion criteria provided P:1U:1

Conservation

PhyloP100: -4.11
Variant links:
Genes affected
TAF1 (HGNC:11535): (TATA-box binding protein associated factor 1) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is the basal transcription factor TFIID, which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes the largest subunit of TFIID. This subunit binds to core promoter sequences encompassing the transcription start site. It also binds to activators and other transcriptional regulators, and these interactions affect the rate of transcription initiation. This subunit contains two independent protein kinase domains at the N- and C-terminals, but also possesses acetyltransferase activity and can act as a ubiquitin-activating/conjugating enzyme. Mutations in this gene result in Dystonia 3, torsion, X-linked, a dystonia-parkinsonism disorder. Alternative splicing of this gene results in multiple transcript variants. This gene is part of a complex transcription unit (TAF1/DYT3), wherein some transcript variants share exons with TAF1 as well as additional downstream DYT3 exons. [provided by RefSeq, Oct 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -4 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
TAF1NR_104387.2 linkuse as main transcriptn.5776C>T non_coding_transcript_exon_variant 40/40
TAF1NR_104388.2 linkuse as main transcriptn.5767C>T non_coding_transcript_exon_variant 40/40
TAF1NR_104389.2 linkuse as main transcriptn.5674C>T non_coding_transcript_exon_variant 39/39

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
TAF1ENST00000437147.8 linkuse as main transcriptn.*247C>T non_coding_transcript_exon_variant 14/141 ENSP00000406517.4 H7C2K9
TAF1ENST00000462588.5 linkuse as main transcriptn.*247C>T non_coding_transcript_exon_variant 11/111 ENSP00000508350.1 A0A804HLH3
TAF1ENST00000467309.5 linkuse as main transcriptn.*363C>T non_coding_transcript_exon_variant 5/61 ENSP00000507353.1 A0A804HJ48

Frequencies

GnomAD3 genomes
AF:
0.0000178
AC:
2
AN:
112177
Hom.:
0
Cov.:
22
AF XY:
0.00
AC XY:
0
AN XY:
34325
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000279
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000188
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000327
AC:
7
AN:
214346
Hom.:
0
Cov.:
0
AF XY:
0.0000120
AC XY:
1
AN XY:
83302
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.000205
Gnomad4 NFE exome
AF:
0.0000260
Gnomad4 OTH exome
AF:
0.000191
GnomAD4 genome
AF:
0.0000178
AC:
2
AN:
112177
Hom.:
0
Cov.:
22
AF XY:
0.00
AC XY:
0
AN XY:
34325
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000279
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000188
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000189

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

X-linked dystonia-parkinsonism Pathogenic:1
Pathogenic, no assertion criteria providedcurationGeneReviewsOct 18, 2012- -
TAF1-related disorder Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesJan 09, 2024The TAF1 c.*65739C>T variant is located in the 3' untranslated region. This variant occurs in a post-coding region of the TAF1 gene and is alternatively known as n.5894C>T (NR_104387.1). This variant has been previously reported in the literature as c.94C>T (p.Arg32Cys) using nomenclature that no longer conforms to current naming conventions (Locus AJ549245.1), and it is often referred to in the literature as DSC3 or the Lubag variant (https://www.ncbi.nlm.nih.gov/books/NBK1489/; Nolte et al. 2003. PubMed ID: 12928496). The DSC3 variant is located within a cluster of five alternative exons (denoted as exons d1-d5) located downstream of the conserved TAF1 exons (exons 1-38) (Herzfeld et al. 2012. PubMed ID: 23184149). Transcript analysis has shown that the exon containing DSC3 can be alternatively spliced onto TAF1 exons 1-37 (Nolte et al. 2003. PubMed ID: 12928496) or can be expressed as a smaller transcript independent of the of TAF1 exons 1-38 (Herzfeld et al. 2012. PubMed ID: 23184149). In a functional study, Herzfeld et al. showed that TAF1 constructs containing DSC3 led to an overall decrease in gene expression (Herzfeld et al. 2013. PubMed ID: 23184149). The DSC3 variant has also been described as one of the seven genetic variants within a haplotype associated with X-linked dystonia-parkinsonism (XDP) in individuals from Panay Island in the Philippines (Domingo et al. 2015. PubMed ID: 25604858). This haplotype has been observed in all affected individuals and includes five single nucleotide variants, a 48-bp deletion, and a 2,627-bp SINE-VNTR-Alu retrotransposon insertion in intron 32 (Domingo et al. 2015. PubMed ID: 25604858). The DSC3 variant or any of the other variants associated with this haplotype have not been conclusively shown to cause XDP (Domingo et al. 2015. PubMed ID: 25604858) and the molecular details regarding XDP pathogenesis is conflicting and not fully understood (Domingo et al. 2015. PubMed ID: 25604858; Capponi et al. 2021. PubMed ID: 34746789). The DSC3 variant is reported in 0.10% of alleles in individuals of East Asian descent in gnomAD. This variant has been interpreted by one laboratory in the ClinVar database as pathogenic (https://www.ncbi.nlm.nih.gov/clinvar/variation/21011/). At this time, the clinical significance of the DSC3 variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.53
DANN
Benign
0.55

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs397509359; hg19: chrX-70749635; API